Skip to main content
Also available in 1 other language

简体中文

Beginner 5 min read

Colorectal Cancer Survival Rates Explained

What NCI's SEER data on colorectal cancer survival means, and doesn't mean, for someone newly diagnosed.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source:National Cancer Institute SEER Cancer Stat Facts: Colorectal Cancer

Review status: AI-assisted, source checked. Not reviewed by a clinician. How we check pages

The short answer

SEER reports an overall five-year relative survival of 65.4% for colorectal cancer. Looking at stage instead of one average is more useful: localized colorectal cancer is 91.3% while distant (metastatic) disease is 16.9%. Screening finds many colorectal cancers early, when they are most treatable.

  • A survival statistic describes a large group diagnosed years ago — not a prediction for any one person.

  • For colorectal cancer, the five-year relative survival rate for everyone combined was 65.4% (diagnosed 2016–2022).

  • Stage at diagnosis makes a large difference: localized disease is 91.3% versus 16.9% for distant (metastatic) disease.

  • Screening can catch colorectal cancer early, or prevent it, by finding and removing polyps before they become cancer.

Choose how you want to read this

The whole article, with every detail and caution.

This page explains colorectal cancer survival numbers and what they can and cannot tell you. It is for people with colorectal cancer and the people close to them.

Before you look at the numbers

Three things are true about the numbers below. Please read all three before you look at any percentage.

First, a "5-year relative survival rate" describes a large group of people who were diagnosed years ago. It is not a prediction about you. Everyone's cancer, body, and treatment plan are different.

Second, this data lags behind today's care. All of these figures reflect people diagnosed between 2016 and 2022. Treat them as estimates. NCI notes that statistics may not reflect the newest treatments.

Third, an all-stages number blends two very different groups: people whose cancer was found early and people whose cancer had already spread. The stage-specific numbers below tell you more than one blended average. And "5-year" is just a measuring window. It is not a life expectancy, and it is not a deadline.

The SEER numbers for colorectal cancer

SEER reports an overall five-year relative survival of 65.4% for colorectal cancer diagnosed between 2016 and 2022. The stage-specific table is more useful. It shows how much survival depends on how early the cancer is found.

About 34% of colorectal cancers are found at the localized stage, 37% regional, and 23% distant.

Stage at diagnosis5-year relative survival
Localized — confined to where it started91.3%
Regional — spread to regional lymph nodes75.2%
Distant — spread to other parts of the body16.9%
Unknown/unstaged49.7%

What "relative survival" actually means

Relative survival compares two groups. One group has colorectal cancer. The other group is the same age and sex, but does not have it. Say the rate is 100%. That would mean the cancer group was as likely to reach 5 years as the other group. It is not the share of people who are free of cancer. It is not the share of people who die from the cancer itself.

Why early detection and tumor testing matter

The stage table above shows how much finding colorectal cancer early matters. NCI says screening can find cancer early, when it may be easier to treat. It can also detect and remove precancerous growths (polyps) before they become cancer. Colonoscopy can remove polyps during the exam. Your doctor may also suggest biomarker tests on the tumor. These help predict how you may respond to certain targeted therapy drugs.

What actually changes your outlook

A statistic describes a group. Your outlook depends on things specific to you. Here are the main ones.

  • Stage — how far the cancer has spread, as shown in the table above.
  • Grade — how abnormal the cancer cells look, and how fast they tend to grow.
  • Biomarker test results — can help predict whether certain targeted drugs are likely to work.
  • How your cancer responds — early scans and labs often say more than the first numbers.
  • Your overall health — other health problems, age, and fitness shape treatment and recovery.
  • Access to care — a quick diagnosis, specialist care, and finishing treatment all matter.

Questions for your care team

  • Which SEER stage describes my cancer, and what is its five-year number?
  • Has my tumor had biomarker tests, and which results matter for me?
  • How do my age and overall health change these statistics for me?
  • Are there newer treatments available now that this data doesn't reflect yet?
  • Beyond the general statistics, what does my team expect in my case?
  • Where can I find support for how it feels to hear these numbers?

If these numbers are hard to hear

These numbers can leave you scared, numb, or overwhelmed. That is normal. It does not mean you are handling your diagnosis the wrong way. Many people take the numbers in slowly, or with someone in the room. Others skip the numbers until they feel ready. Cancer Anxiety and Uncertainty covers the fear these numbers can stir up. It is also worth telling your care team how much detail you want, and when.

Sources

A clinician in a white coat holds a tablet and gestures while talking with a patient in a gown and surgical cap, with a cross-sectional CT image on a wall monitor behind them.

Common questions

What does 65.4% five-year relative survival mean for colorectal cancer?

It means that, on average, people with colorectal cancer were about 65.4% as likely to be alive 5 years later as people of the same age and sex without colorectal cancer. It blends every stage together, from early to advanced.

Why is the stage-specific number so different from the overall number?

The overall number blends people found early, when colorectal cancer is most treatable, with people found later. Stage makes a large difference — see the table above. Localized colorectal cancer usually has a much higher five-year relative survival than distant (metastatic) disease.

Does this number predict what will happen to me?

No. This is a statistic about a large group of people, not a prediction about you. Your age, overall health, tumor biology, and how your colorectal cancer responds to treatment all shape your individual outlook in ways a group statistic cannot capture.

Is this the most current data available?

It is the most recent data SEER has published, but it still reflects people diagnosed in 2016–2022. NCI notes that statistics may not reflect current treatments, so ask your team how the numbers apply to you.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Last updated: 2026-08-17Next planned review: 2027-08-03

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.